3X5 SPECIAL OPPORTUNITY FUND
3x5 Special Opportunity Fund, L.P. specializes in later-stage companies within the healthcare and clean-tech sectors.
3X5 SPECIAL OPPORTUNITY FUND
Founded:
2011-01-01
Status:
Active
Contact:
(503) 808-9645
Email Addresses:
[email protected]
Technology used in webpage:
SPF MediaElement.js VideoJS Mixpanel MailChannels DreamHost Hosting Dreamhost DNS
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Susquehanna Growth Equity
Susquehanna Growth Equity invests in growth stage technology companies in the software, information services, and internet.
Current Employees Featured
Nicholas Walrod
Nicholas Walrod Principal @ 3x5 Special Opportunity Fund Principal 2011-01-01
Anthony Arnerich
Anthony Arnerich Managing Director, General Partner, and Chairman @ 3x5 Special Opportunity Fund Managing Director, General Partner, and Chairman
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-03-25 | Arch Oncology | 3x5 Special Opportunity Fund investment in Series B - Arch Oncology | 50 M USD |
2017-08-01 | Amplyx Pharmaceuticals | 3x5 Special Opportunity Fund investment in Series C - Amplyx Pharmaceuticals | 67 M USD |
2016-09-15 | Securus Medical Group | 3x5 Special Opportunity Fund investment in Series C - Securus Medical Group | 10 M USD |
2016-02-09 | Amplyx Pharmaceuticals | 3x5 Special Opportunity Fund investment in Series B - Amplyx Pharmaceuticals | 8.7 M USD |
2014-09-08 | Tryton Medical | 3x5 Special Opportunity Fund investment in Venture Round - Tryton Medical | 20 M USD |
2014-04-03 | Vapotherm | 3x5 Special Opportunity Fund investment in Series B - Vapotherm | 24 M USD |
2014-03-05 | ZS Pharma | 3x5 Special Opportunity Fund investment in Series D - ZS Pharma | 55 M USD |
2014-01-22 | Vendscreen | 3x5 Special Opportunity Fund investment in Venture Round - Vendscreen | 17.8 M USD |
2013-10-29 | Securus Medical Group | 3x5 Special Opportunity Fund investment in Series B - Securus Medical Group | 6.5 M USD |
2013-04-25 | Vapotherm | 3x5 Special Opportunity Fund investment in Series A - Vapotherm | 29 M USD |